USX:EMMLF - OKYO Pharma Limited OKYO Pharma Limited
Sector: Unknown, Industry: Unknown
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)
Note: This stock seems to be inactive

USD 0.0847    0.0 (-0.12%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

26 Jul 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Gary S. Jacob

Headquarters: US

Employees: 4

Homepage

Description

OKYO Pharma Limited operates as a life sciences and biopharmaceutical company in the United Kingdom. Its pre-clinical development program includes Chemerin for the treatment of ocular inflammation, dry eye disease, and ocular neuropathic pain; and BAM8, a non-opioid analgesic. OKYO Pharma Limited is headquartered in London, the United Kingdom.